A fully automated inpatient transport system

2021 ◽  
pp. 1-8
Author(s):  
Joseph Mendlovic ◽  
Eli Gargir ◽  
David E. Katz
Keyword(s):  
Adverse Events ◽  
Transport System ◽  
Medical Center ◽  
Tertiary Care ◽  
Transport Systems ◽  
Case Review ◽  
Patient Identification ◽  
Retrospective Case ◽  
Tertiary Care Medical Center ◽  
Large Tertiary Care

BACKGROUND: The transport of the inpatients to and from locations inside the hospital can vary in complexity depending on the patient location, status, and logistical needs. Most transport systems have not developed at the same speed as other medically related technologies. We conducted a pilot study of a new automated transport system for patients within the hospital. METHODS: Our innovative system was introduced in January 2020. We present a retrospective case review of all in-patient transport request during April 15, 2020 through May 30, 2020 at the Shaare Zedek Medical Center, Jerusalem, Israel. The system is fully automated and works via smartphone and electronic medical record integration. Transfer requests are processed on the basis of priority, proximity, and availably. RESULTS: During the study period there were 15, 581 transfer requests. Mean times to hospital destinations ranged from 9:25 to 28:02 minutes. Overall, mean times were quicker for emergency and surgical services. Trip times by priority code were likely influence by unmeasured confounders. There were no reported patient identification adverse events. Peak requests occurred during 0900-1500, and at the beginning of the week. CONCLUSION: Our automated in-patient transfer system appears to be efficient, safe, well received, and capable of servicing our large tertiary care medical center. Future controlled studies are needed to assess efficacy, adverse events, and clinical outcomes.

scholarly journals Not a Tumor-Nonspecific Orbital Inflammation

2021 ◽  
Author(s):  
James A. Garrity
Keyword(s):  
Medical Center ◽  
Tertiary Care ◽  
Symptomatic Treatment ◽  
Case Review ◽  
Retrospective Case ◽  
Histologic Subtype ◽  
Orbital Inflammation ◽  
Tertiary Care Medical Center ◽  
Disease Free

Abstract Objective This study was aimed to illustrate the features and complexities of nonspecific orbital inflammation via discussion of two representative cases. Design Present study is a retrospective case review. Setting The study was conducted at a tertiary care medical center. Participants Two patients with nonspecific orbital inflammation were participants of this retrospective study. Main Outcome Measures Outcome of the study was disease-free patients and off all medications. Results At follow-up, both patients are disease free and off all medications. Conclusion Surgery plays a diagnostic and therapeutic role. While the clinical subtype is important for differential diagnosis and symptomatic treatment, the histologic subtype is similarly important. For inflammatory dacryoadenitis, surgery can be therapeutic. For extensive granulomatosis with polyangiitis, debulking surgery may allow better penetration of medications, especially rituximab.

Sa1059 Low Rates of 30-Day Post Colonoscopy Related Major Adverse Events: Data From More Than 5000 Procedures in a Large Tertiary Care Medical Center

2017 ◽  
Vol 85 (5) ◽  
pp. AB174
Author(s):  
Padma Poddutoori ◽  
Babak Gachpaz ◽  
Abhiram Duvvuri ◽  
Sreekar Vennelaganti ◽  
Ramprasad Jegadeesan ◽  
...  
Keyword(s):  
Adverse Events ◽  
Medical Center ◽  
Tertiary Care ◽  
Tertiary Care Medical Center ◽  
Large Tertiary Care ◽  
Events Data ◽  
Major Adverse Events

UPDATE ON PATIENT RADIATION DOSES AT A LARGE TERTIARY CARE MEDICAL CENTER

2001 ◽  
Vol 81 (5) ◽  
pp. 530-535 ◽  
Author(s):  
L. K. Ngutter ◽  
J. M. Koler ◽  
C. H. McCollough ◽  
R. J. Vetter
Keyword(s):  
Medical Center ◽  
Tertiary Care ◽  
Radiation Doses ◽  
Tertiary Care Medical Center ◽  
Large Tertiary Care

Efficacy and safety of intravenous pamidronate for parathyroid hormone-dependent hypercalcemia in hospitalized patients

2021 ◽  
Author(s):  
Rachel Chava Rosenblum ◽  
Orit Twito ◽  
Liat Barzilay-Yoseph ◽  
Erez Ramaty ◽  
Noa Klein ◽  
...  
Keyword(s):  
Parathyroid Hormone ◽  
Serum Calcium ◽  
Medical Center ◽  
Tertiary Care ◽  
Laboratory Data ◽  
Safety Data ◽  
Kidney Injury ◽  
Efficacy And Safety ◽  
Retrospective Case ◽  
Tertiary Care Medical Center

Abstract Context Bisphosphonates are effective for hypercalcemia of malignancy (HOM). Efficacy and safety data for bisphosphonates in parathyroid hormone-related hypercalcemia (PTHRH) are rare, including pamidronate, which is not indicated for this condition. Objective To evaluate the efficacy and safety of pamidronate for moderate-to-severe PTHRH. Design Retrospective case-control study. Setting Tertiary care medical center. Patients Adults hospitalized with serum calcium levels ≥12mg/dL, 29/10/2013–17/12/2019. Interventions Etiology was categorized as PTHRH or PTH-independent. Clinical and laboratory data of PTHRH patients treated with pamidronate (PTHRH-Pam+) were compared to pamidronate-untreated counterparts (PTHRH-Pam-). Results Thirty-four patients with 37 hospitalizations for PTHRH (pamidronate-treated and untreated) met the inclusion criteria. Pamidronate was given in 24/37 cases (64.8%). Admission serum calcium levels for the PTHRH-Pam+ group were higher than for PTHRH-Pam- (14.4mg/dL vs. 13.0mg/dL, p=0.005). Median total pamidronate dose was 60mg (range 30–180mg) in the treated group. Serum calcium decreased 3.5mg/dL for PTHRH-Pam+ vs. 1.6mg/dL for PTHRH-Pam- (p=0.003). No PTHRH-Pam+ patients developed hypocalcemia or acute kidney injury. Nadir serum phosphorus levels were lower in the PTHRH-Pam+ vs. PTHRH-Pam- group (1.7mg/dL vs. 2.4mg/dL, respectively, p=0.005). Three PTHRH-Pam+ patients developed severe hypophosphatemia; all resolved with intravenous and oral supplementation. Seventeen patients underwent parathyroidectomy, of whom 10 received pamidronate within 28 days preoperatively. Post-operatively, 4 developed hypocalcemia and 3 hypophosphatemia. Conclusions This study demonstrates that pamidronate is effective and safe for treating PTHRH, while ensuring close laboratory monitoring of calcium and phosphorus metabolism. Larger, prospective studies are needed to establish the role of pamidronate and other potent bisphosphonates in moderate-to-severe PTHRH.

scholarly journals PGI1 PREVALENCE AND RISK FACTORS FOR DIARRHEA AT A LARGE TERTIARY CARE MEDICAL CENTER

2005 ◽  
Vol 8 (3) ◽  
pp. 369-370
Author(s):  
S Kachroo ◽  
N Kumar ◽  
G Graham ◽  
L Gerard ◽  
T Dao ◽  
...  
Keyword(s):  
Risk Factors ◽  
Medical Center ◽  
Tertiary Care ◽  
Tertiary Care Medical Center ◽  
Large Tertiary Care

Early Clinical Experience with Anidulafungin at a Large Tertiary Care Medical Center

2008 ◽  
Vol 28 (1) ◽  
pp. 64-73 ◽  
Author(s):  
Benjamin D Brielmaier ◽  
Ed Casabar ◽  
Christine M Kurtzeborn ◽  
Peggy S McKinnon ◽  
David J Ritchie
Keyword(s):  
Clinical Experience ◽  
Medical Center ◽  
Tertiary Care ◽  
Early Clinical Experience ◽  
Tertiary Care Medical Center ◽  
Large Tertiary Care

Changes in Pharyngeal Baseline Impedance in Patients With Laryngopharyngeal Reflux

2020 ◽  
Vol 163 (3) ◽  
pp. 563-568
Author(s):  
Jeon Gang Doo ◽  
Su Il Kim ◽  
Jung Min Park ◽  
Oh Eun Kwon ◽  
Young Chan Lee ◽  
...  
Keyword(s):  
Laryngopharyngeal Reflux ◽  
Ph Monitoring ◽  
Medical Center ◽  
Tertiary Care ◽  
Case Series ◽  
Healthy Controls ◽  
Retrospective Case ◽  
Tertiary Care Medical Center ◽  
Intraluminal Impedance ◽  
Reflux Event

Objective Few studies have investigated pharyngeal intraluminal baseline impedance (BI) levels in patients with laryngopharyngeal reflux (LPR). The aim of this study was to compare intraluminal BI levels between patients with LPR and healthy controls. Study Design Retrospective case series. Setting Tertiary care medical center. Subjects and Methods We conducted a retrospective analysis of 24-hour multichannel intraluminal impedance (MII)–pH monitoring results from patients with suspected LPR complaining of reflux symptoms. Patients with suspected LPR were divided into 2 groups according to the 24-hour MII-pH monitoring (LPR group: patients with symptoms with reflux events ≥1, symptom but no reflux [SNR] group: patients with symptoms but no reflux event). Healthy controls were recruited and also underwent 24-hour MII-pH monitoring. We compared the esophageal and pharyngeal BI levels and ratios between 3 groups. Results Pharyngeal BI levels in the LPR group were significantly higher than in the healthy controls. In addition, the pharyngeal BI levels in the SNR group were significantly higher than in the healthy controls. All ratios of pharyngeal to distal esophageal BI levels in the LPR and SNR group were significantly higher than in the healthy controls. However, there were no significant differences in esophageal BI levels and ratios between the 3 groups. Conclusion We found that the pharyngeal BI levels were higher in patients with LPR than in healthy controls. In addition, the pharyngeal BI levels measured by 24-hour MII-pH monitoring in patients with LPR symptoms, but without a reflux episode, were higher than in the healthy controls.

scholarly journals Risk Factors for Resistance to β-Lactam/β-Lactamase Inhibitors and Ertapenem in Bacteroides Bacteremia

2015 ◽  
Vol 59 (8) ◽  
pp. 5049-5051 ◽  
Author(s):  
Janessa M. Smith ◽  
Edina Avdic ◽  
Pranita D. Tamma ◽  
Long Zhang ◽  
Karen C. Carroll ◽  
...  
Keyword(s):  
Risk Factors ◽  
Case Control Study ◽  
Medical Center ◽  
Tertiary Care ◽  
Case Control ◽  
Retrospective Case ◽  
Content Type ◽  
Development Of Resistance ◽  
Tertiary Care Medical Center ◽  
Control Study

ABSTRACTThe objective of this study was to determine risk factors for the development of resistance to β-lactams/β-lactamase inhibitors (βL/βLIs) and ertapenem amongBacteroidesspecies bacteremia. We conducted a retrospective case-control study of 101 adult patients withBacteroidesspecies bacteremia at a 1,051-bed tertiary care medical center. The duration of exposure to βL/βLIs (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.08 to 2.31) was the only independent risk factor for resistance.

Sign in / Sign up

Export Citation Format

Share Document